- Case Report
- Open access
- Published:
Diagnostic challenge of Creutzfeldt-Jakob disease in a patient with multimorbidity: a case-report
BMC Neurology volume 23, Article number: 346 (2023)
Abstract
Background
Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and ultimately fatal neurodegenerative condition caused by prions. The clinical symptoms of CJD vary with its subtype, and may include dementia, visual hallucinations, myoclonus, ataxia, (extra)pyramidal signs and akinetic mutism. In the early course of disease however, several clinical symptoms of CJD may mimic those of co-existing morbidities.
Case presentation
We report a male in his 60s with a history of situs inversus totalis and Churg Strauss syndrome, who presented with speech fluency disturbances, neuropsychiatric symptoms and allodynia, a few months after becoming a widower. Initially presumed a bereavement disorder along with a flare-up of Churg Strauss, his symptoms gradually worsened with apraxia, myoclonic jerks and eventually, akinetic mutism. MRI revealed hyperintensities at the caudate nucleus and thalami, while the cerebrospinal fluid was positive for the 14-3-3 protein and the real-time quick test, making the diagnosis of CJD highly probable. This case illustrates the complexities that may arise in diagnosing CJD when pre-existing multimorbidity may cloud the clinical presentation. We also discuss the potential mechanisms underlying the co-occurrence of three rare conditions (situs inversus totalis, Churg Strauss syndrome, CJD) in one patient, taking into consideration the possibility of coincidence as well as common underlying factors.
Conclusions
The diagnosis of CJD may be easily missed when its clinical symptoms are obscured by those of pre-existing (rare) multimorbidity. This case highlights that when the multimorbidity has neurological manifestations, an extensive evaluation remains crucial to establish the diagnosis, minimize the risk of prion-transmission and provide appropriate guidance to patients and their caregivers.
Background
Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive and invariably fatal neurodegenerative disorder caused by prions. Prions are misfolded proteins, formed by conversion of the normal cellular prion protein with an alpha-helical structure (PrPc) to a β-pleated scrapie (PrPSc) form, that predispose to spongiform encephalopathy [1]. Based on its origin, four types of CJD are currently distinguished: sporadic, familial, iatrogenic, and the variant form. Sporadic CJD (sCJD) accounts for 85–90% of all CJD cases and manifests when normal prion protein spontaneously misfolds into PrPSc, typically affecting individuals of about 65 years old [2]. Familial CJD is inherited and results from mutations in the prion protein gene (PRNP), accounting for 5–10% of all cases, with an earlier age of onset of around 40–50 years [3]. Variant CJD (vCJD), which is related to bovine spongiform encephalopathy (also known as ‘mad cow disease’), is caused by consuming meat products contaminated with prions, affecting less than 1% of all CJD cases [4]. Iatrogenic CJD, also affecting less than 1% of cases, is related to exposure to a known source, such as contaminated medical instruments or growth hormone injections [5]. The annual incidence of CJD is about 1–2 cases per million people, and surveillance programs are active worldwide to monitor the disease, [6], [7] according to well-defined criteria with high sensitivity (92.2%) [8]. Although the clinical symptoms of CJD are known to vary among subtypes, they generally include a rapid decline in cognitive function, motor symptoms, myoclonus, and eventually akinetic mutism. In the early course of disease however, cardinal features of CJD may be obscured by those of pre-existing multimorbidity, which can result in a diagnostic delay that carries a risk of transmission. To illustrate the above, we report a case of a man in his 60s, with a history of situs inversus totalis and Churg Strauss syndrome who had an atypical presentation of CJD. His multimorbidity complicated the diagnosis, and posed a diagnostic challenge between the sporadic and variant form of the disease. We discuss the neurologic examination, laboratory assessments and radiologic findings, along with a discussion of potential mechanisms underlying the co-occurrence of these three conditions in the same patient.
Case presentation
In early 2020, the Dutch National Surveillance Center for Creutzfeldt-Jakob Disease (CJD) received a report from the chief neurologist of a previously independent, 63-year-old Asian male. The patient was referred to the neurology outpatient clinic due to suspected dementia, following a 1-year history of disturbances in speech fluency, memory loss, and behavioral changes. The issues in speech fluency started at the end of 2018, shortly after the patient’s spouse had passed away and were initially believed to be part of a bereavement disorder. The patient used to be proficient in both Dutch and his mother tongue, but over the course of 2019, he experienced difficulty recalling words and started stuttering in both languages. According to his daughter, he also experienced problems in short- and long-term memory, with increasingly worsening anger outbursts.
The patients’ medical history consisted of situs inversus totalis (Fig. 1) and eosinophilic granulomatosis with polyangiitis (EGPA), better known as Churg Strauss syndrome (CSS). The diagnosis of CSS was established in 1998, based on a combination of clinical criteria, including asthma, peripheral blood eosinophilia, systemic vasculitis of the medium and small vessels, glomerulonephritis and mononeuritis multiplex. Blood tests, including antineutrophil cytoplasmic antibodies (p-ANCA and c-ANCA) supported the diagnosis. Extended details of the patient’s diagnosis of CSS are noted in Supplementary File 1. There was no history of surgery, blood transfusions, hormonal injections, or relevant travel history after 1980, and no family history of dementia or prion disease. The prescribed drugs included amitriptyline, pregabalin, diuretics and prednisone. Concurrent to the neuropsychiatric symptoms mentioned earlier, the patient had been experiencing worsening allodynia, which was attributed to small fiber neuropathy as a part of CSS. Accordingly, the dosage of amitriptyline and pregabalin was increased in an attempt to alleviate the symptoms, but without the desired effect. As the patient’s stuttering, memory problems, anger outbursts, and allodynia continued to worsen despite changes to his treatment regimen for CSS throughout 2019, he was eventually referred to the neurology outpatient clinic for suspected dementia.
Investigations
During examination at the neurology outpatient clinic in early 2020, the patient appeared lethargic, unable to follow directions and demonstrated a loss of ability to speak or understand Dutch, consistent with akinetic mutism. A full cranial nerve examination was conducted, during which he exhibited repeated sleep episodes accompanied by myoclonic jerks. No facial asymmetry or abnormalities in tone, power, or sensation were observed. Reflexes were symmetric in all extremities and Babinski reflexes were absent. The gait was unsteady, but without ataxia. The patient had no mental capacity to perform higher-order cognitive tasks, such as the Mini-Mental State Examination (MMSE).
Laboratory tests, including basic blood count, non-fasting glucose level, liver function, renal function, electrolytes, and inflammatory markers were all within normal range (Table 1). Magnetic resonance imaging (MRI) showed ventricular widening due to generalized atrophy, along with hyperintensities at the caudate nucleus and thalami, which were more prominent on the left side compared to the right (Fig. 2). Fluid-attenuated inversion recovery (FLAIR) and diffusion weighted imaging (DWI) revealed cortical hyperintensities on the left side, suggestive of CJD. However, the MRI quality was compromised due to the patient’s movement, rendering it unreliable. No pleiocytosis was observed in the cerebrospinal fluid and both protein and glucose levels were normal (Table 2). The 14-3-3 and RT-QuIC tests were both positive. It is worth noting that the RT-QuIC test has a much higher sensitivity and specificity to detect prion protein in the cerebrospinal fluid than the 14-3-3 test [9]. The PRNP gene was sequenced, revealing heterozygosity at codon 129 (methionine/valine), but no mutations were found. The electroencephalogram (EEG) indicated diffuse slowing of background activity with paradoxical alpha waves (8–12 Hz) during blinking, but without triphasic wave complexes or epileptiform activity.
Differential diagnosis
For at least a year (end of 2018–2019), the neuropsychiatric symptoms and allodynia were considered to be part of a persistent bereavement disorder alongside an aggravating CSS neuropathy, which had been treated by the general practitioner without much success. The patient’s deteriorating symptoms, including short- and long-term memory problems, prompted referral to a neurologist for suspected dementia in early 2020. The differential diagnosis at the time included frontotemporal dementia, Alzheimer’s disease, psychiatric disorders, vascular dementia, and inflammatory/metabolic disorders. However, none of these conditions could be confirmed based on the clinical features and investigations. CJD was suspected once the patient developed apraxia, myoclonus, and akinetic mutism in the following months, and was deemed probable once hyperintensities were found on MRI and both 14-3-3 and RT-QuIC test were positive.
After settling upon the diagnosis of CJD, determining the subtype was another challenge. We learned that the patient owned a catering company for many years, where he prepared and consumed beef amongst other products. Consistent with vCJD, the duration of illness was longer than 6 months, and both neuropsychiatric symptoms and persistent painful sensory symptoms (allodynia) were present early in the disease course. Nevertheless, the patient’s age, chronological order of symptoms, MRI (no evident bilateral pulvinar signs), positive RT-QuIC test and heterozygosity at codon 129 were more consistent with sCJD than vCJD (Fig. 3). Iatrogenic and familial CJD were unlikely, given the absence of invasive procedures or mutations on the PRNP gene. Considering all of the above, a clinical diagnosis of probable sCJD was made [10].
Outcome and follow-up
Two months after establishing the diagnosis, the patient’s condition deteriorated rapidly and after being admitted to a nursing home, he passed away due to aspiration pneumonia. A brain autopsy for diagnostic confirmation was discussed with the family, but no permission was obtained.
Discussion
This patient’s case illustrates the diverse clinical presentation of CJD in the context of multimorbidity, that resulted in considerable diagnostic delay. Besides coincidence, several mechanisms could underlie such an atypical presentation of CJD.
CSS is recognized as a systemic vasculitis affecting small-to-medium-sized vessels, that often extends to the nervous system [11]. Central nervous system vasculitis, as well as peripheral neuropathy, emerged among the top 10 misdiagnoses in a large study consisting of histopathologically confirmed sCJD cases [12]. This highlights the necessity of a thorough diagnostic workup when a patient with rare multimorbidity presents with clinical symptoms that may fulfill criteria for more than 1 disease. For instance, the allodynia of this patient was initially linked to peripheral neuropathy, which is a common neurologic manifestation of CSS. However, about 40% of individuals with the sporadic form of CJD show depositions of PrPSc in the peripheral nervous system, which can also elicit a neuropathy [13]. Â A worsening allodynia during the early disease course of CJD, furthermore complies with the criterium of painful sensory symptoms required for the variant form of CJD, [14] but is atypical for the sporadic form. On the other hand, behavioral changes that had been linked to a persistent bereavement disorder can well be neuropsychiatric manifestations of either vCJD or sCJD [15]. Physicians relying on diagnostic criteria may therefore not properly include CJD in the differential diagnosis, or may experience difficulty in distinguishing the subtype, when a patient is affected by multiple conditions.
Another uncommon occurrence was the stuttering that the patient presented with, which is a focal clinical symptom. About 1% of CJD cases present with an isolated language disorder as the primary clinical symptom [16]. Although lateralization for language was one of the earliest observations of brain asymmetry in humans, computed tomography studies have shown that petalia, referring to the protrusion of one cerebral hemisphere relative to the other, are among the most prominent brain asymmetries [17]. In individuals with situs solitus, this includes a combination of a right frontal lobe petalia and a left occipital lobe petalia. Interestingly, individuals with situs inversus usually retain lateralization of language to the left hemisphere, but exhibit a reversal in these petalia [18]. Both reversed petalia and reduced petalia result in an aberrant cerebral architecture and have been linked to stuttering [19]. While speech disturbances were not reported during the patients childhood, it is possible that the spongiform encephalopathy served as a trigger. Research on asymmetry in visceral organs and its association with brain function, [20], as well as studies focusing on brain asymmetry, [21] are still emerging and may provide additional insights on why the language circuit may be particularly vulnerable. Thus far, the evidence that genes controlling left/right visceral asymmetry are involved in neurological disorders predominantly stems from studies on handedness [22].
With only 1 to 2 cases diagnosed per million individuals, CJD is an exceptionally rare neurodegenerative disorder. The prevalence of CSS is 1 in 70,000-100,000 individuals and only 1 in 10,000 individuals have situs inversus totalis. Assuming complete independence, the probability of encountering a similar case as the one described is the multiplication of these separate probabilities, namely 1,43 × 10− 15. Such small probability would likely make this case a unique occurrence in human history. While the case presents unique challenges to reaching the CJD diagnosis, it also highlights the importance of a comprehensive workup amidst rare multimorbidity. Another hypothesis on the co-occurrence of these conditions revolves around the notion that PrPc is involved in a wide variety of functions in the human body, [23] including: the regulation of the immune response by activating T-cells, neuronal differentiation, signal transduction and synaptic transmission, as well as both pro-apoptotic or anti-apoptotic properties (protection against anti-oxidative stress). Due to these pleiotropic effects of PrPc, the search for common causal mechanisms between CJD, situs inversus totalis as well as CSS remains a challenging endeavor.
Conclusion
In this case-report, we describe the intricacies of diagnosing CJD, when the clinical presentation is obscured by rare multimorbidity. We highlight the importance of a comprehensive work-up for determining the CJD type, which is particularly important for variant CJD. Although the concurrent presence of multiple rare disorders in one patient is statistically unique and could well be a chance finding, several common underlying mechanisms are proposed, that can be explored in future studies.
Data Availability
The medical record of the patient contains all the necessary data that was used for this case report. Given the privacy concerns, regulations and informed consent provided by the patient and their guardian, this record cannot be made publicly available. Further information can be obtained upon contacting the corresponding author.
Abbreviations
- CJD:
-
Creutzfeldt-Jakob disease
- PRNP:
-
a protein coding gene
- PrP:
-
prion protein
- sCJD:
-
sporadic form of Creutzfeldt-Jakob disease
- vCJD:
-
variant form of Creutzfeldt-Jakob disease
- MRI:
-
magnetic resonance imaging
- FLAIR:
-
Fluid-attenuated inversion recovery
- DWI:
-
Diffusion-weighted imaging
- RT-QuIC:
-
real-time quaking-induced conversion test
- MMSE:
-
Mini-Mental State Examination
References
Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 1993;90:10962–6.
Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11:618–28.
Masters CL, Gajdusek DC, Gibbs CJ Jr. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease. Brain. 1981;104:535–58.
Brown P, Will RG, Bradley R, Asher DM, Detwiler LJE. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. 2001;7:6.
Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18:901–7.
Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659–68.
Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Reviews Neurol. 2021;17:362–79.
Watson N, Hermann P, Ladogana A, et al. Validation of revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for sporadic Creutzfeldt-Jakob Disease. JAMA Netw open. 2022;5:e2146319.
Fiorini M, Iselle G, Perra D et al. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci 2020;21.
Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91:e331–8.
Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc. 1995;70:337–41.
Paterson RW, Torres-Chae CC, Kuo AL, et al. Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol. 2012;69:1578–82.
Baiardi S, Redaelli V, Ripellino P, et al. Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery & Psychiatry 2019;90:424–427.
Macleod MA, Stewart GE, Zeidler M, Will R, Knight R. Sensory features of variant Creutzfeldt-Jakob disease. J Neurol. 2002;249:706–11.
Wall CA, Rummans TA, Aksamit AJ, Krahn LE, Pankratz VS. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci. 2005;17:489–95.
Caine D, Nihat A, Crabb P, et al. The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature. PLoS ONE. 2018;13:e0190818–8.
Toga AW, Thompson PM. Mapping brain asymmetry. Nat Rev Neurosci. 2003;4:37–48.
Kennedy DN, O’Craven KM, Ticho BS, Goldstein AM, Makris N, Henson JW. Structural and functional brain asymmetries in human situs inversus totalis. Neurology. 1999;53:1260–0.
Foundas AL, Corey DM, Angeles V, Bollich AM, Crabtree-Hartman E, Heilman KM. Atypical cerebral laterality in adults with persistent developmental stuttering. Neurology. 2003;61:1378–85.
Vingerhoets G, Gerrits R, Bogaert S. Atypical brain functional segregation is more frequent in situs inversus totalis. Cortex. 2018;106:12–25.
Herzog NJ, Magoulas GD. Brain asymmetry detection and machine learning classification for diagnosis of early dementia. Sens (Basel) 2021;21.
Brandler WM, Paracchini S. The genetic relationship between handedness and neurodevelopmental disorders. Trends Mol Med. 2014;20:83–90.
Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta. 2007;1772:629–44.
Acknowledgments
We thank the Dutch National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu) with whom we collaborate for the national surveillance of Creutzfeldt-Jakob disease. We extend our gratitude to the laboratory staff of the Department of Epidemiology at the Erasmus Medical Center of Rotterdam. Additional information on the diagnosis of Churg Strauss syndrome was kindly provided to us by J.M.R. Willemsen, internist and nephrologist at the Amsterdam University Medical Center.
Funding
The authors report no targeted funding.
Author information
Authors and Affiliations
Contributions
Design of work: A.Y., M.K.I., J.B., M.A.I. Acquisition and analysis: J.B., A.Y. Interpretation of data: J.B., A.Y., M.K.I., M.A.I. Writing and submission: A.Y., M.K.I., J.B., M.A.I. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This report was written in compliance with the Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. In accordance, written informed consent was obtained from the legal guardian of the patient.
Consent for publication
Written informed consent to publish this case report was provided by the legal guardian.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yaqub, A., Ikram, M.K., Blankevoort, J. et al. Diagnostic challenge of Creutzfeldt-Jakob disease in a patient with multimorbidity: a case-report. BMC Neurol 23, 346 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12883-023-03401-5
Received:
Accepted:
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12883-023-03401-5